tiprankstipranks
Trending News
More News >
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
US Market
Advertisement

Bausch + Lomb Corporation (BLCO) Earnings Dates, Call Summary & Reports

Compare
139 Followers

Earnings Data

Report Date
Feb 25, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.35
Last Year’s EPS
0.25
Same Quarter Last Year
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 29, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with strong revenue growth across multiple segments, particularly in Pharmaceuticals and Vision Care. While there are concerns about gross margin and tariff impacts, the company's recovery from the enVista recall and successful cash flow optimization demonstrate resilience and strategic management.
Company Guidance
During the Bausch + Lomb Third Quarter 2025 Earnings Call, the company provided guidance and updates on its performance metrics and future outlook. The company reported a total revenue of $1.281 billion, marking a 6% year-over-year growth, with Vision Care and Pharmaceuticals segments contributing significantly. The Pharmaceuticals segment saw a 7% increase in revenue to $330 million, with standout products such as Miebo generating $84 million in revenue, representing a 71% year-over-year increase. The Vision Care segment grew by 6%, driven by robust performances in eye vitamins and contact lenses, with Daily SiHy offerings up by 24% and Biotrue growing by 7%. The Surgical segment reported a 1% increase in revenue despite the enVista recall, with implantables up by 2%. The company maintained its full-year revenue guidance at $5.05 billion to $5.15 billion, projecting a constant currency growth of 5% to 7%. Adjusted EBITDA guidance was updated to $870 million to $910 million, driven by strong business performance. Bausch + Lomb emphasized its strategic focus on financial excellence, operational excellence, and innovation, with plans to further discuss its 3-year plan and pipeline at the upcoming Investor Day.
Steady Revenue Growth
Total company revenue for the quarter was $1.281 billion, reflecting a year-over-year growth of 6% across all segments.
Pharmaceutical Segment Success
Miebo delivered $84 million of revenue in Q3 with a 71% increase year-over-year and TRx growth of 110%. Vision Care revenue increased by 6%.
Strong Performance in Vision Care
Vision Care revenue of $736 million increased by 6%, driven by growth in consumer and contact lenses. Blink reported a 37% growth, Artelac 24%, and eye vitamins 12%.
Growth in Premium IOLs
27% constant currency revenue growth in premium IOLs, with enVista intraocular lenses contributing significantly.
Successful Cash Flow Optimization
Adjusted cash flow from operations was $161 million with a 66% conversion to EBITDA.

Bausch + Lomb Corporation (BLCO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BLCO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
0.35 / -
0.25
Oct 29, 2025
2025 (Q3)
0.16 / 0.18
0.175.88% (<+0.01)
Jul 30, 2025
2025 (Q2)
0.06 / 0.07
0.13-46.15% (-0.06)
Apr 30, 2025
2025 (Q1)
0.02 / -0.07
0.07-200.00% (-0.14)
Feb 19, 2025
2024 (Q4)
0.23 / 0.25
0.244.17% (+0.01)
Oct 30, 2024
2024 (Q3)
0.16 / 0.17
0.22-22.73% (-0.05)
Jul 31, 2024
2024 (Q2)
0.13 / 0.13
0.18-27.78% (-0.05)
May 01, 2024
2024 (Q1)
0.07 / 0.07
0.1-30.00% (-0.03)
Feb 21, 2024
2023 (Q4)
0.17 / 0.24
0.234.35% (<+0.01)
Nov 01, 2023
2023 (Q3)
0.19 / 0.22
0.31-29.03% (-0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BLCO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 29, 2025
$15.20$15.47+1.78%
Jul 30, 2025
$14.65$13.71-6.42%
Apr 30, 2025
$13.72$11.56-15.74%
Feb 19, 2025
$16.35$16.30-0.31%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bausch + Lomb Corporation (BLCO) report earnings?
Bausch + Lomb Corporation (BLCO) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
    What is Bausch + Lomb Corporation (BLCO) earnings time?
    Bausch + Lomb Corporation (BLCO) earnings time is at Feb 25, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BLCO EPS forecast?
          BLCO EPS forecast for the fiscal quarter 2025 (Q4) is 0.35.

            Bausch + Lomb Corporation (BLCO) Earnings News

            BLCO Earnings: Bausch + Lomb Outperforms in Q4, Shares Jump
            Premium
            Market News
            BLCO Earnings: Bausch + Lomb Outperforms in Q4, Shares Jump
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis